Thrombin generation: phenotypic quantitation

被引:78
作者
Brummel-Ziedins, KE [1 ]
Pouliot, RL [1 ]
Mann, KG [1 ]
机构
[1] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA
关键词
assay; phenotype; thrombin;
D O I
10.1046/j.1538-7933.2003.00576.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An individual's ability to generate thrombin following tissue factor stimulus was evaluated in 13 healthy male donors in a 6-month study. Thrombin generation in whole blood collected by phlebotomy, contact pathway suppressed by the presence of 100 mug mL(-1) corn trypsin inhibitor, was initiated by the addition of 5 pM tissue factor/10 nM phospholipid. Reactions were quenched at 20 min by the addition of an ethylenediaminetetraacetic acid (EDTA), benzamidine, FPRck cocktail. Thrombin generation was determined by an ELISA for thrombin-antithrombin III (TAT) complex formation. Results showed that the levels of TAT observed varied from 245 to 775 nM. Thrombin production was consistent within each individual, CVi = 11.6%, but varied significantly within the group, CVg = 25.2%, and correlated inversely with an individual's clotting time (r = -0.54, P = 0.07). No correlations were individually observed between TAT and C-reactive protein, antithrombin III, factors II, V, VII, VIII, IX and X, fibrinogen and prothrombin time. However, computer simulations, which integrated each individual's coagulation factor levels using the Speed Rx method (Hockin et al., J Biol Chem 2002; 277: 18322), predicted maximum active thrombin levels (ranging from calculated values of 220-500 nM) consistent with the empirically determined values. Overall, these data suggest that thrombin generated in whole blood exclusively by tissue factor stimulation can be used as an integrative phenotypic marker to determine an individual's response to a tissue factor challenge.
引用
收藏
页码:281 / 288
页数:8
相关论文
共 55 条
  • [1] Predicting the pharmacology of thrombin inhibitors
    Adams, TE
    Everse, SJ
    Mann, KG
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (05) : 1024 - 1027
  • [2] The thrombogram in rare inherited coagulation disorders:: Its relation to clinical bleeding
    Al Dieri, R
    Peyvandi, F
    Santagostino, E
    Giansily, M
    Mannucci, PM
    Schved, JF
    Béguin, S
    Hemker, HC
    [J]. THROMBOSIS AND HAEMOSTASIS, 2002, 88 (04) : 576 - 582
  • [3] [Anonymous], 1987, HEMATOL REV
  • [4] SIMPLE METHOD FOR PREPARATION OF HOMOGENEOUS PHOSPHOLIPID VESICLES
    BARENHOLZ, Y
    GIBBES, D
    LITMAN, BJ
    GOLL, J
    THOMPSON, TE
    CARLSON, FD
    [J]. BIOCHEMISTRY, 1977, 16 (12) : 2806 - 2810
  • [5] Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels
    Berkowitz, DE
    White, R
    Li, DC
    Minhas, KM
    Cernetich, A
    Kim, S
    Burke, S
    Shoukas, AA
    Nyhan, D
    Champion, HC
    Hare, JM
    [J]. CIRCULATION, 2003, 108 (16) : 2000 - 2006
  • [6] An integrated study of fibrinogen during blood coagulation
    Brummel, KE
    Butenas, S
    Mann, KG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (32) : 22862 - 22870
  • [7] Brummel KE, 2002, BLOOD, V100, p696A
  • [8] Thrombin functions during tissue factor-induced blood coagulation
    Brummel, KE
    Paradis, SG
    Butenas, S
    Mann, KG
    [J]. BLOOD, 2002, 100 (01) : 148 - 152
  • [9] Oral anticoagulation thresholds
    Brummel, KE
    Paradis, SG
    Branda, RF
    Mann, KG
    [J]. CIRCULATION, 2001, 104 (19) : 2311 - 2317
  • [10] BRUMMEL KE, 2002, PAN VASCULAR MED INT, P287